Skip to content
Nephro Critical Care Society
  • Home
  • About
    • About Us
    • Our Journey
    • Vision, Mission & Objectives
    • Affiliations
  • Activities
    • Quiz OF The Week
    • Knowledge Sharing
    • Training Courses
    • Research
      • GLOBE RRT Survey
    • Literature
    • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Blog
  • Media
    • Gallery
    • Videos
      • CRRT
      • AKI
      • Investigations & Biomarker
      • Fluid Therapy
      • Drug Dosing
      • Journal Scan
      • Other Extracorporeal Therapy
      • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Membership
    • Membership Benefits
    • All Members
    • Plus Members
  • My Account
    • Login
  • Contact Us
  • Home
  • About
    • About Us
    • Our Journey
    • Vision, Mission & Objectives
    • Affiliations
  • Activities
    • Quiz OF The Week
    • Knowledge Sharing
    • Training Courses
    • Research
      • GLOBE RRT Survey
    • Literature
    • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Blog
  • Media
    • Gallery
    • Videos
      • CRRT
      • AKI
      • Investigations & Biomarker
      • Fluid Therapy
      • Drug Dosing
      • Journal Scan
      • Other Extracorporeal Therapy
      • 5th Global Update In Nephro Critical Care POCUS IN NEPHRO CRITICAL CARE (PINC)
  • Membership
    • Membership Benefits
    • All Members
    • Plus Members
  • My Account
    • Login
  • Contact Us

QW12-November 2024

Question 1: Select each option to validate with explanations

Clinical Case Scenario

A 35-year-old male patient with severe hepatic encephalopathy due to liver failure presents with confusion, lethargy, and asterixis. Laboratory tests show significantly elevated ammonia levels (210 µmol/L) and impaired kidney functions (urea 55 mmol/L and creatinine 210 µmol/L). Lactate and bicarbonate levels in blood gas are at 10 mmol/L and 14 mmol/L respectively. Despite maximal medical therapy, including lactulose and rifaximin, the patient's condition worsens. Continuous Renal Replacement Therapy (CRRT) is initiated.

Question: What is the primary rationale for using CRRT in this patient, and what key technical considerations should be noted?
😉

Right Answer:A. To provide continuous clearance of ammonia and maintain hemodynamic stability; consider using a high-efficiency dialysis filter and anticoagulation management.

In a patient with severe hepatic encephalopathy and hyperammonemia, CRRT is employed primarily for continuous clearance of ammonia and to maintain hemodynamic stability. This mode of dialysis provides a more controlled and gradual removal of toxins compared to intermittent hemodialysis, which can be better tolerated by critically ill patients. While fluid management and electrolyte correction (Option B) are important in CRRT, the primary reason in this case is ammonia clearance. Removal of small solutes (Option C) and nutritional support (Option D) are relevant but not the primary focuses here.

Clinical Pearls: CRRT and hyperammonemia in hepatic dysfunction

CRRT can be beneficial in the management of hyperammonemia due to hepatic dysfunction, particularly in cases of acute liver failure. In a recent retrospective observational study involving 54 patients with acute liver failure, ammonia levels significantly decreased throughout CRRT, from a median of 151 µmol/L to 52 µmol/L by day 5.
A high-efficiency Dialysis Filter is essential for effectively clearing ammonia. These filters have higher permeability and larger pore sizes, allowing for better clearance of small molecules like ammonia than standard hemodialysis filters. The recommended CRRT dose is typically around 50 mL/kg/h of effluent flow rate. This higher dose helps reduce ammonia levels faster, targeting levels below 100 µmol/L.
Anticoagulation Management is challenging in patients with liver failure due to coagulopathy in ALF patients.
Early initiation (started within 4 hours of diagnosis) and prolonged use of CRRT is most effective.
CRRT can improve survival by preventing severe hyperammonemia and its complications.

😭

Wrong Answer: B. To manage fluid overload and electrolyte imbalances; consider adjusting dialysate composition

😭

Wrong Answer: C. To improve removal of small solutes; consider using low-efficiency filters for longer sessions

😭

Wrong Answer: D. To decrease protein catabolism; consider nutritional support during CRRT



Reference:

1. Warrillow S, Fisher C, Bellomo R. Correction and control of hyperammonemia in acute liver failure: the impact of continuous renal replacement timing, intensity, and duration. Critical care medicine. 2020 Feb 1;48(2):218-24.
2. Fisher C, Baldwin I, Fealy N, Naorungroj T, Bellomo R. Ammonia clearance with different continuous renal replacement therapy techniques in patients with liver failure. Blood Purification. 2022 Oct 17;51(10):840-6.
3. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, US Acute Liver Failure Study Group. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018 Feb;67(2):711-20.
Nephro Critical Care Society

All rights reserved